GlycoMimetics Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- L3Harris CEO steps down amid conduct review, shares drop
- Oil settles up over $2 as Iran war stalemate stokes supply concerns
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
GlycoMimetics (GLYC) Prices 3.3M Common Stock Offering at $6.10/Share
June 17, 2016 9:06 AM EDTGlycoMimetics, Inc. (NASDAQ: GLYC), a clinical stage biotechnology company focused on the discovery and development of novel glycomimetic drugs, today announced the pricing of its underwritten public offering of 3,300,000 shares of its common stock at a price to the public of $6.10 per... More
GlycoMimetics (GLYC) 2.7M Offering Said to Price at $6.10/Share - Bloomberg
June 17, 2016 8:57 AM EDTGlycoMimetics (NASDAQ: GLYC) 2.7M Offering Said to Price at $6.10/Share - Bloomberg
... More